• 1
    Ferlay J, Shin H, Bray F, et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010. Available at:, accessed on 16/11/2012.
  • 2
    Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:64959.
  • 3
    Kogevinas M, Garcia-Closas M, Trichopoulos D. Urinary bladder cancer. In: Adami H, Hunter D, Trichopoulos D, eds. Textbook of Cancer epidemiology. New York: Oxford University Press, 2008:57396.
  • 4
    Silverman D, Devesa S, Moore L, et al. Bladder cancer. In: Schottenfeld D, Fraumeni JJ, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 2006.
  • 5
    Bouvard V, Baan RA, Grosse Y, et al. Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol 2012;13:33940.
  • 6
    Gjoerup O, Chang Y. Update on human polyomaviruses and cancer. Adv Cancer Res 2010;106:151.
  • 7
    Husseiny MI, Anastasi B, Singer J, et al. A comparative study of Merkel cell, BK and JC polyomavirus infections in renal transplant recipients and healthy subjects. J Clin Virol 2010;49:13740.
  • 8
    Newton R, Ribeiro T, Casabonne D, et al. Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort. Br J Cancer 2005;93:13056.
  • 9
    Polesel J, Gheit T, Talamini R, et al. Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. Br J Cancer 2012;106:2226.
  • 10
    Weinreb DB, Desman GT, Amolat-Apiado MJ, et al. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 2006;34:2013.
  • 11
    Roberts IS, Besarani D, Mason P, et al. Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer 2008;99:13836.
  • 12
    Guey LT, Garcia-Closas M, Murta-Nascimento C, et al. Genetic susceptibility to distinct bladder cancer subphenotypes. Eur Urol 2010;57:28392.
  • 13
    Randhawa PS, Gupta G, Vats A, et al. Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 2006;13:105763.
  • 14
    Viscidi RP, Khanna N, Tan CS, et al. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis 2011;53:7115.
  • 15
    Viscidi RP, Rollison DE, Sondak VK, et al. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011;18:173743.
  • 16
    Viscidi RP, Rollison DE, Viscidi E, et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003;10:27885.
  • 17
    Tolstov YL, Knauer A, Chen JG, et al. Asymptomatic primary Merkel cell polyomavirus infection among adults. Emerg Infect Dis 2011;17:137180.
  • 18
    Monini P, Rotola A, Di Luca D, et al. DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology 1995;214:2739.
  • 19
    Fioriti D, Pietropaolo V, Dal Forno S, et al. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol 2003;16:2838.
  • 20
    Rollison DE, Sexton WJ, Rodriguez AR, et al. Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer 2007;120:124851.
  • 21
    Loyo M, Guerrero-Preston R, Brait M, et al. Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer 2010;126:29916.
  • 22
    Robles C, Poloczek A, Casabonne D, et al. Antibody response to Merkel cell polyomavirus associated with incident lymphoma in the Epilymph case-control study in Spain. Cancer Epidemiol Biomarkers Prev 2012;21:15928.
  • 23
    IARC monographs on the evaluation of carcinogenic risks to humans: Tobacco smoke and involuntary smoking, 2004 ed., vol. 83. Lyon: IARC Press, 2004.
  • 24
    Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. J Intern Med 2011;269:25869.
  • 25
    Touze A, Gaitan J, Arnold F, et al. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol 2010;48:176770.